Shares of Advanced Cell Technology have settled neatly into the area of eighteen cents after a run that began on historical news last December that launched the stock to highs of over a quarter from the five cent mark.

The price action continued into the open of 2011 after the initiation of a sec...

Read more

AMRN: Keep an eye on shares of Amarin this week.

After flying higher on news late last year that one AMR101 Phase III trial had produced positive trial results - and then news again in January that the ongoing ANCHOR Phase III trial would be completed ahead of schedule, the company announced during ...

Read more